Christopher H. Chay

885 total citations
26 papers, 737 citations indexed

About

Christopher H. Chay is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher H. Chay has authored 26 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher H. Chay's work include Prostate Cancer Treatment and Research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Christopher H. Chay is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Christopher H. Chay collaborates with scholars based in United States, Australia and Poland. Christopher H. Chay's co-authors include Kenneth J. Pienta, Carlton R. Cooper, Hyung-Lae Lee, Laurie K. McCauley, Jasmine Bhatia, Evan T. Keller, Russell S. Taichman, C C Harris, Xin Wei Wang and Vanessa Ott and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLANT PHYSIOLOGY.

In The Last Decade

Christopher H. Chay

21 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher H. Chay United States 10 332 316 189 160 155 26 737
D. Fan United States 14 404 1.2× 359 1.1× 168 0.9× 68 0.4× 119 0.8× 23 804
Kanji Hojo Japan 11 560 1.7× 242 0.8× 93 0.5× 105 0.7× 261 1.7× 21 974
Hillary J. Millar United States 9 483 1.5× 356 1.1× 96 0.5× 89 0.6× 150 1.0× 14 773
Andreas Enns Germany 9 506 1.5× 289 0.9× 59 0.3× 122 0.8× 129 0.8× 9 889
Guoyu Yu United States 16 408 1.2× 315 1.0× 195 1.0× 32 0.2× 193 1.2× 39 779
Maya Zigler United States 17 565 1.7× 300 0.9× 64 0.3× 109 0.7× 184 1.2× 23 961
Vered Givant-Horwitz Norway 11 360 1.1× 197 0.6× 59 0.3× 170 1.1× 168 1.1× 12 639
Tetsuji Sawada Japan 20 494 1.5× 392 1.2× 138 0.7× 58 0.4× 199 1.3× 38 928
Archontoula Stoffel United States 12 548 1.7× 259 0.8× 80 0.4× 32 0.2× 166 1.1× 15 826
Kim M. Dulski United States 9 275 0.8× 306 1.0× 94 0.5× 80 0.5× 126 0.8× 9 582

Countries citing papers authored by Christopher H. Chay

Since Specialization
Citations

This map shows the geographic impact of Christopher H. Chay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher H. Chay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher H. Chay more than expected).

Fields of papers citing papers by Christopher H. Chay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher H. Chay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher H. Chay. The network helps show where Christopher H. Chay may publish in the future.

Co-authorship network of co-authors of Christopher H. Chay

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher H. Chay. A scholar is included among the top collaborators of Christopher H. Chay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher H. Chay. Christopher H. Chay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stish, Bradley J., Jones T. Nauseef, Michael Humeniuk, et al.. (2026). Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer. Journal of Clinical Oncology. JCO2501486–JCO2501486.
2.
3.
Mazza, Gina L., Jones T. Nauseef, Michael Humeniuk, et al.. (2024). Alliance A222001: A randomized, double-blind, placebo controlled phase II study of oxybutynin versus placebo for the treatment of hot flashes in men receiving androgen deprivation therapy.. Journal of Clinical Oncology. 42(17_suppl). LBA12004–LBA12004. 1 indexed citations
4.
Lin, Po‐Ju, Christopher H. Chay, Benjamin Esparaz, et al.. (2024). The effect of YOCAS©® yoga on cancer-related fatigue and quality of life in older (60+) vs. younger (≤ 59) cancer survivors: Secondary analysis of a nationwide, multicenter, phase 3 randomized controlled trial. Journal of Geriatric Oncology. 15(8). 102076–102076. 1 indexed citations
5.
6.
Eyre, Toby A., Nirav N. Shah, Martin Dreyling, et al.. (2022). BRUIN MCL-321: Phase III Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in BTK Inhibitor Naive Mantle Cell Lymphoma. Future Oncology. 18(36). 3961–3969. 14 indexed citations
7.
8.
Smith, David C., Christopher H. Chay, Rodney L. Dunn, et al.. (2003). Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone‐refractory prostate carcinoma. Cancer. 98(2). 269–276. 30 indexed citations
9.
Cooper, Carlton R., Christopher H. Chay, Hyung-Lae Lee, et al.. (2003). Stromal factors involved in prostate carcinoma metastasis to bone. Cancer. 97(S3). 739–747. 148 indexed citations
10.
Chay, Christopher H., Carlton R. Cooper, Saravana M. Dhanasekaran, et al.. (2002). A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines. Urology. 60(5). 760–765. 81 indexed citations
11.
Chay, Christopher H., et al.. (2002). Antimetastatic Drugs in Prostate Cancer. PubMed. 1(1). 14–19. 7 indexed citations
12.
Cooper, Carlton R., Christopher H. Chay, & Kenneth J. Pienta. (2002). New Discoveries in Prostate Cancer Biology and Treatment. Expert Opinion on Therapeutic Targets. 6(1). 123–127. 2 indexed citations
13.
Cooper, Carlton R., Christopher H. Chay, & Kenneth J. Pienta. (2002). The Role of αvβ3 in Prostate Cancer Progression. Neoplasia. 4(3). 191–194. 190 indexed citations
14.
Chay, Christopher H.. (2001). Adjuvant and neoadjuvant therapy in prostate cancer. Seminars in Oncology. 28(1). 3–12. 32 indexed citations
15.
Chay, Christopher H. & David C. Smith. (2001). Adjuvant and neoadjuvant therapy in prostate cancer. Seminars in Oncology. 28(1). 3–12. 8 indexed citations
16.
Chay, Christopher H. & Kenneth J. Pienta. (2000). Evidence for lectin signaling to the nuclear matrix: Cellular interpretation of the glycocode. Journal of Cellular Biochemistry. 79(S35). 123–129. 8 indexed citations
17.
Mohler, James L., et al.. (1995). Detection of candidates for cancer cell motility inhibitory protein in the Dunning adenocarcinoma model. Clinical & Experimental Metastasis. 13(6). 474–480. 5 indexed citations
18.
Forrester, Kathleen, Shawn E. Lupold, Vanessa Ott, et al.. (1995). Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent.. PubMed. 10(11). 2103–11. 91 indexed citations
19.
Broadwater, Anne, et al.. (1993). Zea mI, the maize homolog of the allergen-encoding Lol pI gene of rye grass. Gene. 131(2). 227–230. 31 indexed citations
20.
Chay, Christopher H., et al.. (1992). Purification of Maize Pollen Exines and Analysis of Associated Proteins. PLANT PHYSIOLOGY. 100(2). 756–761. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Fan Breakdown of academic impact, for papers by Kanji Hojo Breakdown of academic impact, for papers by Hillary J. Millar Breakdown of academic impact, for papers by Andreas Enns Breakdown of academic impact, for papers by Guoyu Yu Breakdown of academic impact, for papers by Maya Zigler Breakdown of academic impact, for papers by Vered Givant-Horwitz Breakdown of academic impact, for papers by Tetsuji Sawada Breakdown of academic impact, for papers by Archontoula Stoffel Breakdown of academic impact, for papers by Kim M. Dulski
Rankless by CCL
2026